Evidence map›Paper›PMID 23486969›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Serotonin 1A receptors alter expression of movement representations.

Kathleen Scullion, Jeffery A Boychuk, Glenn R Yamakawa, Justin T G Rodych, Stan T Nakanishi, Angela Seto, Victoria M Smith, Ryan W McCarthy, Patrick J Whelan, Michael C Antle and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  6. Review
  7. Article
  8. Review
  9. Monoaminergic Modulation of Motor Cortex Function.Frontiers in neural circuits · 2017
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Kathleen ScullionHotchkiss Brain Institute, Department of Neuroscience, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
Jeffery A Boychuk
Glenn R Yamakawa
Justin T G Rodych
Stan T Nakanishi
Angela Seto
Victoria M Smith
Ryan W McCarthy
Patrick J Whelan
Michael C Antle
Quentin J Pittman
G Campbell Teskey
Allen Institute for Brain Science · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Serotonin has a myriad of central functions involving mood, appetite, sleep, and memory and while its release within the spinal cord is particularly important for generating movement, the corresponding role on cortical movement representations (motor maps) is unknown. Using adult rats we determined that pharmacological depletion of serotonin (5-HT) via intracerebroventricular administration of 5,7 dihydroxytryptamine resulted in altered movements of the forelimb in a skilled reaching task as well as higher movement thresholds and smaller maps derived using high-resolution intracortical microstimulation (ICMS). We ruled out the possibility that reduced spinal cord excitability could account for the serotonin depletion-induced changes as we observed an enhanced Hoffman reflex (H-reflex), indicating a hyperexcitable spinal cord. Motor maps derived in 5-HT1A receptor knock-out mice also showed higher movement thresholds and smaller maps compared with wild-type controls. Direct cortical application of the 5-HT1A/7 agonist 8-OH-DPAT lowered movement thresholds in vivo and increased map size in 5-HT-depleted rats. In rats, electrical stimulation of the dorsal raphe lowered movement thresholds and this effect could be blocked by direct cortical application of the 5-HT1A antagonist WAY-100135, indicating that serotonin is primarily acting through the 5-HT1A receptor. Next we developed a novel in vitro ICMS preparation that allowed us to track layer V pyramidal cell excitability. Bath application of WAY-100135 raised the ICMS current intensity to induce action potential firing whereas the agonist 8-OH-DPAT had the opposite effect. Together our results demonstrate that serotonin, acting through 5-HT1A receptors, plays an excitatory role in forelimb motor map expression.

Indexed as

5,7-Dihydroxytryptamine8-Hydroxy-2-(di-n-propylamino)tetralinAction PotentialsAnalysis of VarianceAnimalsBrain MappingChromatography, High Pressure LiquidForelimbH-ReflexMaleMiceMice, KnockoutMicroinjectionsMotor CortexMovementNeurons5,7-Dihydroxytryptamine8-Hydroxy-2-(di-n-propylamino)tetralinPiperazinesReceptor, Serotonin, 5-HT1ASerotoninSerotonin AgentsTryptophan HydroxylaseWAY 100135

Identifiers

PMID23486969
PMCPMC6619014
OpenAlexW2047613208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.